{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T20:38:51Z","timestamp":1760042331150},"reference-count":33,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2007,5,1]],"date-time":"2007-05-01T00:00:00Z","timestamp":1177977600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinica Chimica Acta"],"published-print":{"date-parts":[[2007,5]]},"DOI":"10.1016\/j.cca.2007.02.028","type":"journal-article","created":{"date-parts":[[2007,2,23]],"date-time":"2007-02-23T16:36:49Z","timestamp":1172248609000},"page":"14-20","source":"Crossref","is-referenced-by-count":14,"title":["New biochemical markers: From bench to bedside"],"prefix":"10.1016","volume":"381","author":[{"given":"Martina","family":"Zaninotto","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Monica Maria","family":"Mion","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Enrica","family":"Novello","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sara","family":"Altinier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mario","family":"Plebani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cca.2007.02.028_bib1","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/S0735-1097(00)00804-4","article-title":"Myocardial infarction redefined: a consensus document of The Joint European society of cardiology\/American College of cardiology committee for redefinition of myocardial infarction","volume":"36","author":"Alpert","year":"2000","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cca.2007.02.028_bib2","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1161\/CIRCULATIONAHA.106.627505","article-title":"Redefinition of myocardial infarction: prospective evaluation in the community","volume":"114","author":"Roger","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.cca.2007.02.028_bib3","doi-asserted-by":"crossref","first-page":"2373","DOI":"10.1093\/eurheartj\/ehl226","article-title":"Redefinition of myocardial infarction: new challenges and opportunities (editorial)","volume":"27","author":"Roger","year":"2006","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cca.2007.02.028_bib4","doi-asserted-by":"crossref","first-page":"e560","DOI":"10.1161\/01.CIR.0000148983.88334.80","article-title":"CDC\/AHA Workshop on markers of inflammation and cardiovascular disease: application to clinical and public health practice. Clinical use of inflammatory markers in patients with cardiovascular diseases: a background paper","volume":"110","author":"Biasucci","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.cca.2007.02.028_bib5","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1161\/01.CIR.0000087480.94275.97","article-title":"From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: Part I","volume":"108","author":"Naghavi","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.cca.2007.02.028_bib6","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.1161\/01.CIR.0000087481.55887.C9","article-title":"From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: Part II","volume":"108","author":"Naghavi","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.cca.2007.02.028_bib7","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/S0736-4679(00)00255-9","article-title":"Novel assay for cobalt-albumin binding and its potential as a marker for myocardial ischemia\u2014a preliminary report","volume":"19","author":"Bar-Or","year":"2000","journal-title":"J Emerg Med"},{"key":"10.1016\/j.cca.2007.02.028_bib8","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1373\/clinchem.2003.024760","article-title":"Diagnostic accuracy and prognostic relevance of the measurement of cardiac natriuretic peptides: a review","volume":"50","author":"Clerico","year":"2004","journal-title":"Clin Chem"},{"key":"10.1016\/j.cca.2007.02.028_bib9","doi-asserted-by":"crossref","first-page":"2335","DOI":"10.1161\/CIRCULATIONAHA.104.482570","article-title":"Biomarkers of cardiovascular disease: molecular basis and practical considerations","volume":"113","author":"Vasan","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.cca.2007.02.028_bib10","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1016\/j.ahj.2005.05.014","article-title":"The diagnostic and prognostic impact of the redefinition of acute myocardial infarction: lessons from the Global Registry of Acute Coronary Events (GRACE)","volume":"151","author":"Goodman","year":"2006","journal-title":"Am Heart J"},{"key":"10.1016\/j.cca.2007.02.028_bib11","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1515\/cclm.2001.39.2.175","article-title":"Quality specifications for cardiac troponin assays","volume":"39","author":"Panteghini","year":"2001","journal-title":"Clin Chem Lab Med"},{"key":"10.1016\/j.cca.2007.02.028_bib12","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1007\/s005990050064","article-title":"Cardiac markers: present and future","volume":"29","author":"Plebani","year":"1999","journal-title":"Int J Clin Lab Res"},{"key":"10.1016\/j.cca.2007.02.028_bib13","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/j.ahj.2004.04.030","article-title":"Diagnostic value of serial measurement of cardiac markers in patients with chest pain: limited value of adding myoglobin to troponin I for exclusion of myocardial infarction","volume":"148","author":"Eggers","year":"2004","journal-title":"Am Heart J"},{"key":"10.1016\/j.cca.2007.02.028_bib14","first-page":"A135","article-title":"Analytical and clinical evaluation of the evidence cardiac panel","volume":"52","author":"Mion","year":"2006","journal-title":"Clin Chem"},{"key":"10.1016\/j.cca.2007.02.028_bib15","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1515\/CCLM.2006.246","article-title":"Analytical and clinical evaluation of a new heart-type fatty acid-binding protein automated assay","volume":"44","author":"Zaninotto","year":"2006","journal-title":"Clin Chem Lab Med"},{"key":"10.1016\/j.cca.2007.02.028_bib16","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1161\/01.CIR.0000135581.79161.35","article-title":"Acute coronary syndrome biomarkers: the need for more adequate reporting","volume":"110","author":"Jaffe","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.cca.2007.02.028_bib17","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1373\/49.4.581","article-title":"Evaluation of human serum albumin cobalt binding assay for the assessment of myocardial ischemia and myocardial infarction","volume":"49","author":"Bhagavan","year":"2003","journal-title":"Clin Chem"},{"key":"10.1016\/j.cca.2007.02.028_bib18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jacc.2006.02.056","article-title":"Biomarkers in acute cardiac disease","volume":"48","author":"Jaffe","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cca.2007.02.028_bib19","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1373\/clinchem.2004.046292","article-title":"Future biomarkers for detection of ischemia and risk stratification in acute coronary syndrome","volume":"51","author":"Apple","year":"2005","journal-title":"Clin Chem"},{"key":"10.1016\/j.cca.2007.02.028_bib20","doi-asserted-by":"crossref","first-page":"e568","DOI":"10.1161\/01.CIR.0000149077.87074.DE","article-title":"CDC\/AHA workshop on markers of inflammation and cardiovascular disease: application to clinical and public health practice. Ability of inflammatory markers to predict disease in asymptomatic patients: a background paper","volume":"110","author":"Wilson","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.cca.2007.02.028_bib21","doi-asserted-by":"crossref","first-page":"e545","DOI":"10.1161\/01.CIR.0000148980.87579.5E","article-title":"CDC\/AHA workshop on markers of inflammation and cardiovascular disease: application to clinical and public health practice. Report from the laboratory science discussion group","volume":"110","author":"Myers","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.cca.2007.02.028_bib22","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1056\/NEJMoa042378","article-title":"C-reactive protein levels and outcomes after statin therapy","volume":"352","author":"Ridker","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cca.2007.02.028_bib23","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.jacc.2006.04.085","article-title":"Short- and long-term risk stratification in acute coronary syndromes: the added value of quantitative ST-segment depression and multiple biomarkers","volume":"48","author":"Westerhout","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cca.2007.02.028_bib24","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1016\/j.jacc.2005.10.055","article-title":"Early inflammation and risk of long-term development of heart failure and mortality in survivors of acute myocardial infarction","volume":"47","author":"Suleiman","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cca.2007.02.028_bib25","first-page":"A23","article-title":"Measurement of C-reactive protein: a report from an Italian survey","volume":"44","author":"Zaninotto","year":"2006","journal-title":"Clin Chem Lab Med"},{"key":"10.1016\/j.cca.2007.02.028_bib26","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1038\/nature04672","article-title":"Targeting C-reactive protein for the treatment of cardiovascular disease","volume":"440","author":"Pepys","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.cca.2007.02.028_bib27","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1161\/hh2401.101272","article-title":"CD40 signaling and plaque instability","volume":"89","author":"Schonbeck","year":"2001","journal-title":"Circ Res"},{"key":"10.1016\/j.cca.2007.02.028_bib28","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1161\/01.CIR.0000028962.04520.01","article-title":"Platelet derived CD40L. The switch hitting player of cardiovascular disease","volume":"106","author":"Andr\u00e9","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.cca.2007.02.028_bib29","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1161\/01.CIR.100.6.614","article-title":"Enhanced levels of soluble and membrane-bound CD40 ligand in patients with unstable angina","volume":"100","author":"Aukrust","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.cca.2007.02.028_bib30","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1161\/01.CIR.0000088521.04017.13","article-title":"Soluble CD40L: risk prediction after acute coronary syndrome","volume":"108","author":"Varo","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.cca.2007.02.028_bib31","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S1567-5688(03)00030-8","article-title":"ADMA: a novel risk factor that explains excess cardiovascular event rate in patients with end-stage renal disease","volume":"4","author":"Boger","year":"2003","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.cca.2007.02.028_bib32","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1080\/07853890500472151","article-title":"Asymmetric dimethylarginine (ADMA): a novel risk marker in cardiovascular medicine and beyond","volume":"38","author":"Boger","year":"2006","journal-title":"Ann Med"},{"key":"10.1016\/j.cca.2007.02.028_bib33","doi-asserted-by":"crossref","first-page":"2536","DOI":"10.1161\/01.ATV.0000242801.38419.48","article-title":"Asymmetric dimethylarginine predicts major adverse cardiovascular events in patients with advanced peripheral artery disease","volume":"26","author":"Mittermayer","year":"2006","journal-title":"Arterioscler Thromb Vasc Biol"}],"container-title":["Clinica Chimica Acta"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898107000964?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898107000964?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,9]],"date-time":"2019-01-09T04:26:51Z","timestamp":1547008011000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009898107000964"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,5]]},"references-count":33,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2007,5]]}},"alternative-id":["S0009898107000964"],"URL":"https:\/\/doi.org\/10.1016\/j.cca.2007.02.028","relation":{},"ISSN":["0009-8981"],"issn-type":[{"value":"0009-8981","type":"print"}],"subject":[],"published":{"date-parts":[[2007,5]]}}}